Peter Blume-Jensen

Insider Reports History

Entity
Individual
Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, MA
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact for Peter Blume-Jensen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Blume-Jensen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. President and CEO, Director Common Stock 2.34M $15.1M $6.44 Nov 21, 2024 Direct
Acrivon Therapeutics, Inc. President and CEO, Director Common Stock 317K $2.04M $6.44 Nov 21, 2024 Indirect
Acrivon Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 225K Mar 1, 2024 Direct
Acrivon Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 90.1K Mar 1, 2024 Indirect

Insider Reports Filed by Peter Blume-Jensen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Nov 21, 2024 1 -$128K 4 Nov 25, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2024 2 -$477K 4 Nov 18, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Aug 21, 2024 1 -$732K 4 Aug 23, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Aug 14, 2024 1 -$420K 4 Aug 16, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. May 14, 2024 1 -$459K 4 May 16, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Mar 1, 2024 2 $0 4 Nov 27, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Feb 14, 2024 1 -$142K 4 Feb 16, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2023 1 -$1.21M 4 Nov 16, 2023 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Aug 21, 2023 1 $0 4 Aug 23, 2023 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. May 31, 2023 2 $130K 4 Jun 1, 2023 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 6 $0 4 Nov 16, 2022 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 President and CEO, Director